Skip to main content
. 2021 Mar 29;181(7):995–997. doi: 10.1001/jamainternmed.2021.0484

Figure. Identification of Brand-Name Drugs Susceptible to “Skinny Labeling,” 2015-2019.

Figure.

Exclusion of drugs that had not entered the market was determined by using the corresponding National Drug Code numbers to search for a prescription claim prior to March 20, 2020, in Optum's deidentified Clinformatics Data Mart database.